You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

plasmapheresis

Showing 26 - 50 of 249
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Kidney Transplantation Trial in Toulouse (Large volume specific immunoadsorption, Double Filtration Plasmapheresis)

Unknown status
  • Kidney Transplantation
  • Large volume specific immunoadsorption
  • Double Filtration Plasmapheresis
  • Toulouse, France
    University Hospital Toulouse (Hospital Rangueil)
Aug 24, 2020

Pure Autonomic Failure, Amyotrophic Lateral Sclerosis, Postural Orthostatic Tachycardia Syndrome Trial in Rozzano

Completed
  • Pure Autonomic Failure
  • +3 more
  • Immunoabsorption/plasmapheresis procedure
  • Rozzano, Italy
    Humanitas Research Hospital
May 3, 2021

Guillain-Barre Syndrome Trial (Mini-pool Intravenous Immunoglobulin (MP-IVIG), plasma exchange)

Unknown status
  • Guillain-Barre Syndrome
  • Mini-pool Intravenous Immunoglobulin (MP-IVIG)
  • plasma exchange
  • (no location specified)
Jan 12, 2021

Apheresis Related Hypotension Trial in Lakeland, West Des Moines, American Fork (Aurora Xi New Nomogram Software 2.0, Aurora Xi

Not yet recruiting
  • Apheresis Related Hypotension
  • Aurora Xi New Nomogram Software 2.0
  • Aurora Xi Currently Approved Software 1.3
  • Lakeland, Florida
  • +2 more
Nov 3, 2023

Plasmapheresis and Double Filtration Plasmapheresis in Kidney

Completed
  • Kidney Transplant Rejection
  • +2 more
  • plasmapheresis
  • (no location specified)
Nov 4, 2019

Kidney Transplantation, Antibody Mediated Rejection Trial in La Tronche (Sessions of conventional apheresis, Sessions of news

Unknown status
  • Kidney Transplantation
  • Antibody Mediated Rejection
  • Sessions of conventional apheresis
  • Sessions of news apheresis with double filtration
  • La Tronche, France
    Grenoble Alpes University Hospital
Mar 26, 2020

Refractory Hepatic Encephalopathy Trial in New Delhi (Lactulose, Rifaximin, Plasmapheresis)

Withdrawn
  • Refractory Hepatic Encephalopathy
  • New Delhi, Delhi, India
    Institute of Liver and Biliary Sciences
Nov 1, 2019

Transplants and Implants Trial in Cincinnati (plerixafor, Bortezomib, plasmapheresis)

Unknown status
  • Transplants and Implants
  • Cincinnati, Ohio
  • +1 more
Jun 29, 2020

Multiple Sclerosis, Clinically Isolated Syndrome Trial in Ulm (Immunoadsorption, Plasmapheresis)

Completed
  • Multiple Sclerosis
  • Clinically Isolated Syndrome
  • Immunoadsorption
  • Plasmapheresis
  • Ulm, Baden-Württemberg, Germany
    Department of Neurology, University of Ulm
Sep 10, 2019

Pneumonia, Ventilator-Associated, Coronavirus Infection Trial in Ranica, Bergamo (Anti-coronavirus antibodies

Unknown status
  • Pneumonia, Ventilator-Associated
  • Coronavirus Infection
  • Anti-coronavirus antibodies (immunoglobulins)obtained with DFPP from convalescent patients
  • Ranica, BG, Italy
  • +4 more
Jun 5, 2020

Normal Human ImmunoGlobulins: Feasibility of Integrating

Not yet recruiting
  • Immunoglobulins
  • NHIg prescription
  • (no location specified)
Aug 30, 2023

Critical Illness Trial in Canada (Albumin Fluid Resuscitation Optimization Intervention, Usual Practice)

Completed
  • Critical Illness
  • Albumin Fluid Resuscitation Optimization Intervention
  • Usual Practice
  • Calgary, Alberta, Canada
  • +14 more
Oct 31, 2022

Lung Transplant Rejection, Antibody-mediated Rejection Trial (Belatacept, Carfilzomib)

Withdrawn
  • Lung Transplant Rejection
  • Antibody-mediated Rejection
  • (no location specified)
Apr 30, 2019

Coagulopathy, Hemorrhage Trial in Cincinnati (Autologous Spray Dried Plasma)

Not yet recruiting
  • Coagulopathy
  • Hemorrhage
  • Autologous Spray Dried Plasma
  • Cincinnati, Ohio
    Hoxworth Blood Center
Nov 29, 2022

Decreased Immunologic Activity, Antibody-mediated Rejection Trial in Vienna (Combined apheresis)

Terminated
  • Decreased Immunologic Activity
  • Antibody-mediated Rejection
  • Combined apheresis
  • Vienna, Austria
    Division of Medicine III, Dpt. of Nephrology and Dialysis, Medic
Aug 22, 2022

Factors Affecting Mortality in Covid-19 Disease

Completed
  • COVID-19 Pneumonia
  • Mortality
  • covid-19 survival cohort
  • covid-19 mortality cohort
  • Antalya, Turkey
    Akdeniz University School of Medicine, Department of Anesthesiol
Sep 15, 2023

Botulism Trial in Richmond (rBV A/B)

Not yet recruiting
  • Botulism
  • rBV A/B
  • Richmond, California
    California Department of Public Health
Oct 31, 2023

From Convalescent and/or Immunized Donors for Treatment of

Completed
  • COVID-19
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 31, 2023

    Antibody-mediated Rejection, NMO Spectrum Disorder, TTP Trial in Iowa City

    Recruiting
    • Antibody-mediated Rejection
    • +3 more
      • Iowa City, Iowa
        DeGowin blood Center
      Oct 31, 2022

      Transplant Rejection Trial in Worldwide (BIVV020, Intravenous immunoglobulin (IVIg), Rituximab)

      Recruiting
      • Transplant Rejection
      • Westmead, New South Wales, Australia
      • +14 more
      Aug 2, 2022

      Blood Components From Healthy Donors for In Vitro Research Use

      Recruiting
      • Blood Donors
      • +2 more
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Jan 21, 2023

        Alzheimer Trial in Trondheim (ExPlas, Octaplasma, Saline)

        Recruiting
        • Alzheimer Disease
        • Trondheim, Norway
          Department of Neurology and Clinical Neurophysiology, St Olavs H
        Sep 30, 2022

        Acute Optic Neuritis Network:International Study That

        Recruiting
        • Demyelinating Diseases
        • +4 more
        • non-interventional study
        • Aurora, Colorado
        • +25 more
        Oct 31, 2022

        Anticoagulant Reversal Trial in Cincinnati (Fresh Frozen Plasma (FFP), Freeze Dried Plasma (FDP))

        Not yet recruiting
        • Anticoagulant Reversal
        • Fresh Frozen Plasma (FFP)
        • Freeze Dried Plasma (FDP)
        • Cincinnati, Ohio
          Hoxworth Blood Center
        Mar 9, 2021

        Graft Rejection Trial in Germany, United States (Placebo, C1 Esterase Inhibitor (Human))

        Completed
        Has Results
        • Graft Rejection
        • Placebo
        • C1 Esterase Inhibitor (Human)
        • Los Angeles, California
        • +4 more
        Jun 2, 2021